期刊文献+

国际肿瘤化疗药物不良反应评价系统——通用不良反应术语标准4.0版 被引量:492

International evaluation system for adverse events of chemotherapeutic drugs in cancer treatment:CTCAE v4.0
原文传递
导出
摘要 简要介绍通用不良事件术语标准(Common Terminology Criteria Adverse Events,CTCAE)的发展过程。在与通用不良事件术语标准3.0版(Common Terminology Criteria Adverse Events Version3.0,CTCAEv3.0)比较的基础上,对通用不良事件术语标准4.0版(Common Terminology Criteria Adverse Events Version4.0,CTCAEv4.0)的特征进行分析,以评估CTCAE v4.0在肿瘤治疗不良反应评估中的应用前景和趋势。 This article introduces the development of Common Terminology Criteria Adverse Events(CTCAE),and compares the characteristics of Common Terminology Criteria Adverse Events Version 3.0(CTCAE v3.0) with CTCAE v4.0.The essential features of CTCAE v4.0 are reviewed,and the trends and prospects of CTCAE v4.0 in evaluation of adverse events in cancer treatment are analyzed.
出处 《肿瘤》 CAS CSCD 北大核心 2012年第2期142-144,共3页 Tumor
基金 上海市自然科学基金资助项目(编号:11ZR1447200)
关键词 肿瘤 药物疗法 不良反应 评价系统 Neoplasms Drug therapy Adverse reactions Evaluation system
  • 相关文献

参考文献3

二级参考文献6

  • 1International Conference on Harmonisation (ICH). MedDRA(r) Term Selection: Points to Consider: ICH-Endorsed Guide for MedDRA Users [ S]. Release 3.4. Basel, Switzerland, 2004: 11.
  • 2Safety Reporting Requirements for Human Drug and Biological Products. Proposed Rule 68[ S]. Fed Regist,2003;50:12405 - 12497.
  • 3Kubler J, Vonk R, Beimel S, et al. Adverse event analysis and MedDRA: business as usual or challenge [ J]? Drug Inf J, 2005;39:63- 72.
  • 4Mozzicato P. MAGs: a new-and improved-way of thinking[S]. MedDRA Messenger, 2002 : September.
  • 5中国CIPRA通讯[EB/OL].Available from URL:http://www.ciprancaids.org.cn/2004:11.[Accessed May 28,2006].
  • 6International Conference on Harmonisation (ICH). MedDRA Data Retrieval and Presentation: Points to Consider: ICH-Endorsed Guide for MedDRA Users[ S]. release 1.0. Basel, Switzerland, 2004: 11.

共引文献130

同被引文献4519

引证文献492

二级引证文献2750

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部